Home Cart 0 Sign in  

[ CAS No. 55-97-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 55-97-0
Chemical Structure| 55-97-0
Structure of 55-97-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 55-97-0 ]

Related Doc. of [ 55-97-0 ]

Alternatived Products of [ 55-97-0 ]

Product Details of [ 55-97-0 ]

CAS No. :55-97-0 MDL No. :MFCD00011787
Formula : C12H30Br2N2 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 362.19 Pubchem ID :-
Synonyms :
Hexamethonium (bromide);Hexamethonium Dibromide
Chemical Name :N1,N1,N1,N6,N6,N6-hexamethylhexane-1,6-diaminium bromide

Calculated chemistry of [ 55-97-0 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 7
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 82.4
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : -9.34
Log Po/w (XLOGP3) : 3.7
Log Po/w (WLOGP) : -4.03
Log Po/w (MLOGP) : -4.09
Log Po/w (SILICOS-IT) : 1.46
Consensus Log Po/w : -2.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.95
Solubility : 0.0402 mg/ml ; 0.000111 mol/l
Class : Soluble
Log S (Ali) : -3.39
Solubility : 0.147 mg/ml ; 0.000407 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.75
Solubility : 0.00647 mg/ml ; 0.0000179 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.79

Safety of [ 55-97-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P260-P314-P501 UN#:N/A
Hazard Statements:H373 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 55-97-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 55-97-0 ]
  • Downstream synthetic route of [ 55-97-0 ]

[ 55-97-0 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 629-03-8 ]
  • [ 75-50-3 ]
  • [ 55-97-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 9, p. 2998 - 3003
[2] Patent: US2006/36120, 2006, A1, . Location in patent: Page/Page column 4
[3] RSC Advances, 2014, vol. 4, # 91, p. 49846 - 49849
[4] Patent: CN105017032, 2017, B, . Location in patent: Paragraph 0059; 0060; 0061
  • 2
  • [ 66967-77-9 ]
  • [ 55-97-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1963, vol. 6, p. 402 - 405
  • 3
  • [ 59533-63-0 ]
  • [ 55-97-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1963, vol. 6, p. 402 - 405
  • 4
  • [ 71655-17-9 ]
  • [ 55-97-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1963, vol. 6, p. 402 - 405
  • 5
  • [ 18715-38-3 ]
  • [ 55-97-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1963, vol. 6, p. 402 - 405
  • 6
  • [ 57042-08-7 ]
  • [ 55-97-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1963, vol. 6, p. 402 - 405
Same Skeleton Products
Historical Records